Cancer Type: Neurological

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email Patient_Care_Coordination_Center@bjc.org.

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.

 

202011112

Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients with Recurrent Select Rare CNS Cancers

202012017

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1

202012180

A PHASE II STUDY OF CHECKPOINT BLOCKADE IMMUNOTHERAPY IN PATIENTS WITH SOMATICALLY HYPERMUTATED RECURRENT GLIOBLASTOMA

201509033

Computer-based Neurocognitive Assessment in Children with Central Nervous System Tumors Receiving Proton Beam Radiation Therapy

201810185

Effect of rhIL-7-hyFc on increasing lymphocyte counts in patients with newly diagnosed non-severe lymphopenic gliomas following radiation and temozolomide

201903023

Pilot Study of Same-session MR-only Simulation and Treatment with Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine

201908018

Mapping Draining Lymph Nodes in CNS Malignancies

201709026

A Phase II Randomized Trial of Proton vs Photon Therapy (IMRT) for Cognitive Preservation in Patients with IDH Mutant, Low to Intermediate Grade Gliomas